Researchers say the new concept that lithium deficiency could be a cause of Alzheimer’s disease points to a different ...

A promising new treatment, however, may offer a safer path forward.

Perfusion processes have become increasingly important for manufacturing monoclonal antibodies (mAbs) because they can sustain higher cell densities, extend production runs, and boost volumetric ...

Cytiva will serve as the exclusive global distributor of Culture’s Stratyx 250 bioreactor platform and associated consumables.

Digitization has allowed Sanofi to optimize manufacturing and automate document preparation. And now, the firm predicts that ...

Agg-CLNP synergized with abatacept to delay RA-related inflammation and with dexamethasone to prevent flare-ups following ...

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

This generally-regarded-as-safe yeast can be a cost-effective production vehicle for enzymes and antibodies, as well as heterologous proteins.

The speakers hope to stimulate conversation about how regions can remain competitive and while becoming interdependent.

As drug developers face mounting pressure to accelerate discovery timelines without sacrificing quality, QLNS-CHO offers a compelling solution.

HNF1A mutations are found to dysregulate RNA splicing in pancreatic cells, thereby contributing to the onset of diabetes.

A bacteria-based cancer therapy has been engineered that eradicates tumors in immunocompromised mice—no immune cells required.